bannière biohub 2100x452

Welcome to the MabDesign Bio-hub

On the MabDesign Bio-Hub, you’ll find a wealth of information on the biopharmaceutical sector: thematic market analyses, explanatory articles on biopharmaceuticals, biomanufacturing and all that goes with it, as well as our famous immunowatches and bioprocess watches.

As an association representing the biomedical industry, part of our mission is to put our expertise at the service of innovation and the companies behind it. If you haven’t heard of MabDesign yet, we invite you to take a look at our about us page to find out more !

Tags

Human Immunodeficiency Virus

The MabDesign market analysis gives you an overview of market dynamics and projects currently in development for the prevention and treatment of Human Immunodeficiency Virus (HIV).

Experts’ corner : ADCs/ADCs Bispecific

The Experts Corner - Discover our discussion with Alain Beck of Pierre Fabre Laboratories on ADCs/Bispecific ADCs.
ADC, antibody-drug conjugates, conjugués anticorps médicaments

ADCs : antibodies and cytotoxic molecules united against tumours

From Paul Ehrlich’s early “magic bullet” concept to today’s approved therapeutics, Antibody-Drug Conjugates (ADCs) represent a major breakthrough in targeted cancer therapy. By combining the selectivity of monoclonal antibodies with the potency of cytotoxic agents, ADCs aim to eliminate tumor cells while sparing healthy tissues. This article dives into the evolution, design strategies, and key challenges of these complex biologics. 

Therapies based on genome editing

The MabDesign market analysis gives you an overview of market dynamics and projects currently in development for the therapies based on genome editing.
conjugués anticorps-oligonucléotides, antibody oligonucleotides conjugates

Antibody-oligonucleotides conjugates

Each month, MabDesign's market analyses give you an overview of market dynamics and projects in development for a given indication or technology, to help you better understand the constantly evolving market for biomedicines and biomanufacturing. This month, an overview of antibody-oligonucleotide conjugate (AOC) projects currently in development.
Cell therapies, interview, expert's corner

Experts’ corner : Cell therapies

The Experts Corner - Read our interview with Sophie Derenne from the EFS, on the cell therapy market, its challenges and prospects.
thérapies géniques

Gene therapies

This month's MabDesign market analysis gives you an overview of the gene therapy market and projects currently in development.
vecteurs viraux, AAV, adénovirus

Bioproduction of viral vectors: challenges, innovations and market prospects

Viral vectors are essential therapeutic tools for gene therapy and certain vaccines. The growing number of cell and gene therapy products on the market means that the production of viral vectors is an increasingly strategic sector.

Respiratory syncitial virus

This month's MabDesign market analysis gives you an overview of market dynamics and projects in development targeting respiratory syncitial virus (RSV).